BDR Pharma Launches Oral Prostate Cancer Drug BDENZA
January 2, 2024 13:30
BDR Pharmaceuticals introduces Enzalutamide oral solution, BDENZA, for prostate cancer treatment. The company claims it's the first in the world to offer this drug delivery system, providing a more...